Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shang-Fu Hsu

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Medicine|February 3, 2018
Van Buchem disease: First case report in TaiwanShang-Fu Hsu, Chen-Chun Lin
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
HDAC Inhibitor Abrogates LTA-Induced PAI-1 Expression in Pleural Mesothelial Cells and Attenuates Experimental Pleural FibrosisWei-Lin Chen, Mei-Chuan Chen, Shang-Fu Hsu, et al.
Infectious Diseases and Therapy|May 21, 2024
A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19Wang-Da Liu, Po-Hao Feng, Chien-Yu Cheng, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 6, 2024
Class I HLA Alleles Are Associated With an Increased Risk of Osimertinib-Induced HypersensitivityChun-Bing Chen, Chuang-Wei Wang, Chun-Wei Lu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Medicine|February 3, 2018
Van Buchem disease: First case report in TaiwanShang-Fu Hsu, Chen-Chun Lin
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
HDAC Inhibitor Abrogates LTA-Induced PAI-1 Expression in Pleural Mesothelial Cells and Attenuates Experimental Pleural FibrosisWei-Lin Chen, Mei-Chuan Chen, Shang-Fu Hsu, et al.
Infectious Diseases and Therapy|May 21, 2024
A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19Wang-Da Liu, Po-Hao Feng, Chien-Yu Cheng, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 6, 2024
Class I HLA Alleles Are Associated With an Increased Risk of Osimertinib-Induced HypersensitivityChun-Bing Chen, Chuang-Wei Wang, Chun-Wei Lu, et al.
Pageof 1